Christopher Cleary

Vice President, Corporate Development

Chris is Vice President of Corporate Development for Medtronic, with responsibility for acquisitions, dispositions and minority investments. During 2014, Chris led the corporate development efforts for Medtronic’s $50 billion acquisition of Covidien. Since, Chris and the corporate development team have led more than 35 acquisitions, 25 investments and the $6 billion sale of Covidien medical supply assets to Cardinal Health.

Prior to 2014, Chris was CEO of Alesia Capital Services, a management consulting firm for Fortune 500 companies, including Medtronic, Goldman Sachs, Ally, Macquarie Capital and Terex. From 1995 to 2011, Chris led M&A teams within several businesses at GE Capital, closing acquisitions totaling more than $60B across 200+ transactions in the US, Canada, Europe, Asia and Latin America.